欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/2027/001
药品名称Vimetso
活性成分
    • Metformin hydrochloride 850.0 mg
    • vildagliptin 50.0 mg
剂型Film-coated tablet
上市许可持有人Krka d.d. Novo Mesto, Slovenia
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Hungary (HU)
      Glypvicombi 50 mg/850 mg -50 mg/1000 mgfilmtabletta
    • Bulgaria (BG)
      Glypvicombi
    • Cyprus (CY)
      Glypvicombi 50mg/850mg FCT
    • Czechia (CZ)
      Glypvicombi 50mg/850mg potahované tablety
    • Slovakia (SK)
      Vimetso 50 mg/850 mg filmom obalené tablety
    • Slovenia (SI)
    • Malta (MT)
      Vimetso 50 mg/850 mg film-coated tablets
    • Greece (GR)
    • Croatia (HR)
      Vimetso 50 mg/850 mg filmom obložene tablete
    • Poland (PL)
      Vimetsi
    • Latvia (LV)
      Vimetso 50 mg/850 mg apvalkotās tabletes
    • Lithuania (LT)
      Vimetso 50 mg/850 mg plėvele dengtos tabletės
    • Estonia (EE)
许可日期2021/06/16
最近更新日期2025/05/27
药物ATC编码
    • A10BD08 metformin and vildagliptin
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Multiple (Copy) Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase